When analyzing men and women separately, we found that a history of CHD was a weak determinant for MPO-DNA complex levels in men (β -0.14 mAU/mL, 95% CI -0.22;-0.05), but not in women (β -0.07 mAU/mL, 95% CI -0.21;0.08). Here, MPO is linked to coronary artery disorder.